News | ASTRO | October 22, 2020

ASTRO Responds to CMS Announcement on Delayed Radiation Oncology Model Start Date

On Oct. 21, Seema Verma, administrator of the Centers for Medicare & Medicaid Services, tweeted that CMS will delay the Radiation Oncology Model’s launch from Jan. 1 to July 1 

On Oct. 21, Seema Verma, administrator of the Centers for Medicare & Medicaid Services, tweeted that CMS will delay the Radiation Oncology Model’s launch from Jan. 1 to July 1 

Getty Images

October 22, 2020 — In response to the Oct. 21 announcement that the Centers for Medicare and Medicaid Services (CMS) will delay the start date for the Radiation Oncology Model from Jan. 1 to July 1, 2021, the American Society for Radiation Oncology (ASTRO) issued the following statement from Theodore L. DeWeese, M.D., FASTRO, Chair of the ASTRO Board of Directors:

"ASTRO appreciates today’s announcement by CMS Administrator Seema Verma that CMS will delay the Radiation Oncology Model launch from January 1, 2021 until July 1, 2021 based on feedback from ASTRO and other radiation oncology stakeholders. This change is an important recognition of the radiation oncology community’s concerns, and we are pleased and thankful that Administrator Verma listened to the needs of our member radiation oncology practices during these challenging times.

We are hopeful that the delay represents the first step toward full, open engagement with ASTRO on ways to ensure that the RO Model achieves our shared goals of higher quality, lower cost cancer care. We remain seriously concerned with excessive payment cuts in the model that will cause significant financial strain on practices and risk patient access to radiation treatments.

ASTRO is committed to a successful alternative payment model for radiation oncology, and we look forward to working with CMS during the delay period to ensure that the concerns of ASTRO and its more than 10,000 members, as well as cancer patients, members of Congress and other radiation oncology stakeholders are addressed."

For more informaton: www.astro.org

Related Content

A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — and could lead to more accurate cancer therapy.
News | X-Ray | December 03, 2020
December 3, 2020 — A new hybrid X-ray detector deve

Sanjeev Bhalla, M.D.

News | RSNA | December 03, 2020
December 3, 2020 — ...
RSNA’s highest honor – the Gold Medal – was awarded to Ronald L. Arenson, M.D., William T. Thorwarth, Jr., M.D., and Kay H. Vydareny, M.D.

Getty Images

News | RSNA | December 02, 2020
December 2, 2020 — Ji...
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...
Mary C. Mahoney, M.D.

Mary C. Mahoney, M.D.

News | RSNA | December 01, 2020
December 1, 2020 — At the Virtual RSNA 2020 conference, it was a
Resoundant Inc., announced hat it has entered into a strategic partnership with United Imaging Healthcare to begin offering advanced magnetic resonance elastography (MRE) on leading United Imaging MRI systems.
News | Magnetic Resonance Imaging (MRI) | November 30, 2020
November 30, 2020 — Resoundant Inc., announced that it has entered into a strategic partnership with...
James P. Borgstede, M.D.

James P. Borgstede, M.D.

News | Radiology Business | November 29, 2020
November 29, 2020 — RSNA President...